APEN Apollo Endosurgery Inc
Apollo Endosurgery develops medical devices for the diagnosis and treatment of gastrointestinal diseases. The companyâ??s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apolloâ??s products include the X-Tackâ?¢ Endoscopic HeliX Tacking System, the OverStitchâ?¢ Endoscopic Suturing System, the OverStitch Sxâ?¢ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon. Apollo Endosurgery was founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.) Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled in 1998 (Timeline) with the goal to advance the new discipline; their specific focus was the use of long, flexible instruments deployed through a natural orifice in order to diagnose and potentially treat gastrointestinal disorders.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Apollo Endosurgery Inc?
What is the 52-week high for Apollo Endosurgery Inc?
What is the 52-week low for Apollo Endosurgery Inc?
What is Apollo Endosurgery Inc stock price today?
What was Apollo Endosurgery Inc stock price yesterday?
What is the PE ratio of Apollo Endosurgery Inc?
What is the Price-to-Book ratio of Apollo Endosurgery Inc?
What is the 50-day moving average of Apollo Endosurgery Inc?